Opko Health Inc (NASDAQ: OPK) on Friday, soared 4.04% from the previous trading day, before settling in for the closing price of $1.36. Within the past 52 weeks, OPK’s price has moved between $1.15 and $2.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 1.59% over the past five years. The company achieved an average annual earnings per share of -277.08%. With a float of $303.35 million, this company’s outstanding shares have now reached $671.55 million.
Let’s look at the performance matrix of the company that is accounted for 2997 employees. In terms of profitability, gross margin is 24.77%, operating margin of -21.32%, and the pretax margin is -1.45%.
Opko Health Inc (OPK) Insider and Institutional Ownership
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Opko Health Inc is 54.72%, while institutional ownership is 31.34%. The most recent insider transaction that took place on Apr 10 ’25, was worth 169,712. In this transaction CEO & Chairman of this company bought 125,000 shares at a rate of $1.36, taking the stock ownership to the 214,001,448 shares. Before that another transaction happened on Apr 08 ’25, when Company’s CEO & Chairman bought 125,000 for $1.48, making the entire transaction worth $184,650. This insider now owns 213,876,448 shares in total.
Opko Health Inc (OPK) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -277.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.20% during the next five years compared to 32.04% growth over the previous five years of trading.
Opko Health Inc (NASDAQ: OPK) Trading Performance Indicators
Opko Health Inc (OPK) is currently performing well based on its current performance indicators. A quick ratio of 3.13 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.09, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.22 in one year’s time.
Technical Analysis of Opko Health Inc (OPK)
Opko Health Inc (NASDAQ: OPK) saw its 5-day average volume 5.13 million, a positive change from its year-to-date volume of 4.81 million. As of the previous 9 days, the stock’s Stochastic %D was 18.44%. Additionally, its Average True Range was 0.08.
During the past 100 days, Opko Health Inc’s (OPK) raw stochastic average was set at 10.79%, which indicates a significant decrease from 15.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.56% in the past 14 days, which was higher than the 40.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6865, while its 200-day Moving Average is $1.5455. Nevertheless, the first resistance level for the watch stands at $1.4400 in the near term. At $1.4650, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.5100. If the price goes on to break the first support level at $1.3700, it is likely to go to the next support level at $1.3250. The third support level lies at $1.3000 if the price breaches the second support level.
Opko Health Inc (NASDAQ: OPK) Key Stats
Market capitalization of the company is 950.24 million based on 671,550K outstanding shares. Right now, sales total 713,140 K and income totals -53,220 K. The company made 183,640 K in profit during its latest quarter, and 14,030 K in sales during its previous quarter.
